These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28064219)

  • 1. Active and Passive Immunization Against Staphylococcus aureus Periprosthetic Osteomyelitis in Rats.
    Søe NH; Jensen NV; Jensen AL; Koch J; Poulsen SS; Pier GB; Johansen HK
    In Vivo; 2017 Jan; 31(1):45-50. PubMed ID: 28064219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel knee prosthesis model of implant-related osteomyelitis in rats.
    Søe NH; Jensen NV; Nürnberg BM; Jensen AL; Koch J; Poulsen SS; Pier G; Johansen HK
    Acta Orthop; 2013 Feb; 84(1):92-7. PubMed ID: 23409845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.
    Nishitani K; Beck CA; Rosenberg AF; Kates SL; Schwarz EM; Daiss JL
    Clin Orthop Relat Res; 2015 Sep; 473(9):2735-49. PubMed ID: 26013151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection.
    Kropec A; Maira-Litran T; Jefferson KK; Grout M; Cramton SE; Götz F; Goldmann DA; Pier GB
    Infect Immun; 2005 Oct; 73(10):6868-76. PubMed ID: 16177366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.
    Lattar SM; Noto Llana M; Denoël P; Germain S; Buzzola FR; Lee JC; Sordelli DO
    Infect Immun; 2014 Jan; 82(1):83-91. PubMed ID: 24126523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic antibiotic therapy does not significantly improve outcome in a rat model of implant-associated osteomyelitis induced by Methicillin susceptible Staphylococcus aureus.
    Fölsch C; Federmann M; Lakemeier S; Kuehn KD; Kittinger C; Kerwat M; Fuchs-Winkelmann S; Paletta JR; Roessler PP
    Arch Orthop Trauma Surg; 2016 Apr; 136(4):585-92. PubMed ID: 26873243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
    Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
    Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel model for studying hematogenous infection in an experimental setting of implant-related infection by a community-acquired methicillin-resistant S. aureus strain.
    Poultsides LA; Papatheodorou LK; Karachalios TS; Khaldi L; Maniatis A; Petinaki E; Malizos KN
    J Orthop Res; 2008 Oct; 26(10):1355-62. PubMed ID: 18425805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A doxycycline-loaded polymer-lipid encapsulation matrix coating for the prevention of implant-related osteomyelitis due to doxycycline-resistant methicillin-resistant Staphylococcus aureus.
    Metsemakers WJ; Emanuel N; Cohen O; Reichart M; Potapova I; Schmid T; Segal D; Riool M; Kwakman PH; de Boer L; de Breij A; Nibbering PH; Richards RG; Zaat SA; Moriarty TF
    J Control Release; 2015 Jul; 209():47-56. PubMed ID: 25910578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters.
    Varrone JJ; de Mesy Bentley KL; Bello-Irizarry SN; Nishitani K; Mack S; Hunter JG; Kates SL; Daiss JL; Schwarz EM
    J Orthop Res; 2014 Oct; 32(10):1389-96. PubMed ID: 24992290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
    J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.
    Cerca N; Jefferson KK; Maira-Litrán T; Pier DB; Kelly-Quintos C; Goldmann DA; Azeredo J; Pier GB
    Infect Immun; 2007 Jul; 75(7):3406-13. PubMed ID: 17470540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for active and passive immunization against Staphylococcus aureus.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 2006 Feb; 25(2):167-8. PubMed ID: 16462297
    [No Abstract]   [Full Text] [Related]  

  • 14. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
    Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
    J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coating with a novel gentamicinpalmitate formulation prevents implant-associated osteomyelitis induced by methicillin-susceptible Staphylococcus aureus in a rat model.
    Fölsch C; Federmann M; Kuehn KD; Kittinger C; Kogler S; Zarfel G; Kerwat M; Braun S; Fuchs-Winkelmann S; Paletta JR; Roessler PP
    Int Orthop; 2015 May; 39(5):981-8. PubMed ID: 25380688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.
    Nemeth J; Lee JC
    Infect Immun; 1995 Feb; 63(2):375-80. PubMed ID: 7821999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of prophylactic CpG Oligodeoxynucleotide application on implant-associated Staphylococcus aureus bone infection.
    Sethi S; Thormann U; Sommer U; Stötzel S; Mohamed W; Schnettler R; Domann E; Chakraborty T; Alt V
    Bone; 2015 Sep; 78():194-202. PubMed ID: 25959416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring immune responses in a mouse model of fracture fixation with and without Staphylococcus aureus osteomyelitis.
    Rochford ETJ; Sabaté Brescó M; Zeiter S; Kluge K; Poulsson A; Ziegler M; Richards RG; O'Mahony L; Moriarty TF
    Bone; 2016 Feb; 83():82-92. PubMed ID: 26525592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized Mice Exhibit Exacerbated Abscess Formation and Osteolysis During the Establishment of Implant-Associated
    Muthukrishnan G; Wallimann A; Rangel-Moreno J; Bentley KLM; Hildebrand M; Mys K; Kenney HM; Sumrall ET; Daiss JL; Zeiter S; Richards RG; Schwarz EM; Moriarty TF
    Front Immunol; 2021; 12():651515. PubMed ID: 33815412
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.
    Lee JC; Park JS; Shepherd SE; Carey V; Fattom A
    Infect Immun; 1997 Oct; 65(10):4146-51. PubMed ID: 9317020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.